CHARLES SCHWAB INVESTMENT MANAGEMENT INC - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 82 filers reported holding CATALYST BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q2 2021$57,000
-85.6%
13,113
-83.3%
0.00%
Q1 2021$397,000
+22.5%
78,741
+53.7%
0.00%
Q4 2020$324,000
+46.6%
51,2420.0%0.00%
Q3 2020$221,000
-13.3%
51,242
+18.2%
0.00%
Q2 2020$255,000
+12.8%
43,334
+55.8%
0.00%
Q1 2019$226,000
+29.1%
27,815
+25.9%
0.00%
Q4 2018$175,000
-26.8%
22,1000.0%0.00%
Q3 2018$239,000
-19.5%
22,100
-13.1%
0.00%
Q2 2018$297,00025,4280.00%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,635,014$10,830,0004.93%
22NW, LP 1,429,242$5,874,0001.75%
Ghost Tree Capital, LLC 1,000,000$4,110,0001.20%
Sio Capital Management, LLC 623,892$2,564,0000.82%
ACUTA CAPITAL PARTNERS, LLC 365,000$1,500,0000.53%
Nantahala Capital Management 2,432,212$9,996,0000.32%
Parkman Healthcare Partners LLC 133,449$548,0000.14%
Ikarian Capital, LLC 454,346$1,867,0000.13%
Orbimed Advisors 2,711,600$11,145,0000.12%
AlphaCentric Advisors LLC 114,000$469,0000.12%
View complete list of CATALYST BIOSCIENCES INC shareholders